In six European countries, the number of deaths after the use of the Pfizer coronavirus vaccine is significantly higher than after the use of the AstraZeneca vaccine. This is stated in the report of the Swedish-British pharmaceutical company.
The 12-page document provides statistics on the total number of deaths for every million doses of vaccines administered in France, Germany, Norway, Austria, and Italy. These indicators of the drug Pfizer are almost three times higher than that of AstraZeneca.
According to available data, for every million doses of Pfizer vaccine used in France, 45.3 deaths occur, while AstraZeneca vaccines account for 17.9. In Germany, this indicator is at the level of 29.9 and 6.5, respectively, in the UK 20.7 and 24.2, in Norway 164.3 and 44.6, in Austria 47.5 and 7.5, in Italy 10.9 and 7.3.
In the UK, vaccination with the drug from AstraZeneca is used massively and is the main one for some categories of citizens. As of May 26, 72.9% of adults in the country received one dose of the vaccine, and 44.8% received two doses.
The data shows that the risk for those vaccinated with the Pfizer vaccine is higher than that of AstraZeneca.
A decision made for one vaccine (not to use it) can potentially reduce public confidence in other vaccines … Insufficient vaccination will prolong the pandemic, the report says.
The company also recalled that the British regulator and scientists have repeatedly noted that the risk of infection with coronavirus to a large extent exceeds the risks of side effects from vaccination. The company is ready to cooperate with any scientific structures in order to ensure the safety of the vaccine while maintaining full transparency.
In March, complications in patients vaccinated with AstraZeneca began to be reported from various countries. Some, whose age was less than 55 years, began to show thrombosis. The first person died in Austria 10 days after vaccination. Germany, the United Kingdom, and other European countries also reported problems. Some States have suspended the use of the drug as a precautionary measure.